Tirapazamine, also known as SR-4233, is an experimental anticancer drug that is activated in hypoxic conditions. This activation is very useful as this hypoxic state is found in human solid tumors in a common phenomenon known as tumor hypoxia. Hence, tirapazamine is solely activated in those hypoxic areas of solid tumors. It is important to take into conside...
For the treatment of head and neck cancer.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.